Black Rock Inc. Regulus Therapeutics Inc. Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
A detailed history of Black Rock Inc. transactions in Regulus Therapeutics Inc. stock. As of the latest transaction made, Black Rock Inc. holds 3,968,857 shares of RGLS stock, worth $5.44 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,968,857
Previous 68,031
5733.89%
Holding current value
$5.44 Million
Previous $195,000
3543.08%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding RGLS
# of Institutions
70Shares Held
53.5MCall Options Held
13.7KPut Options Held
7K-
Federated Hermes, Inc. Pittsburgh, PA12.9MShares$17.6 Million0.05% of portfolio
-
Nea Management Company, LLC Timonium, MD6.47MShares$8.86 Million0.73% of portfolio
-
Vivo Capital, LLC Palo Alto, CA5MShares$6.85 Million1.54% of portfolio
-
Octagon Capital Advisors LP New York, NY4.85MShares$6.64 Million1.71% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.97MShares$5.43 Million0.0% of portfolio
About Regulus Therapeutics Inc.
- Ticker RGLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 14,634,400
- Market Cap $20M
- Description
- Regulus Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the discovery and development of drugs that targets microRNAs to treat a range of diseases in the United States. Its product candidates include RG-012, an anti-miR targeting miR-21 that is in Phase II clinical trial for the treatment of Alport syndrome, a life-thre...